Get the Stockscreener App
28.08
6.03%
1.37
Surmodics Inc stock is traded at $28.08, with a volume of 197.48K.
It is up +6.03% in the last 24 hours and down -17.10% over the past month.
See More
Previous Close:
$26.71
Open:
$26.73
24h Volume:
197.48K
Relative Volume:
1.32
Market Cap:
$549.47M
Revenue:
$138.20M
Net Income/Loss:
$5.52M
P/E Ratio:
73.89
EPS:
0.38
Net Cash Flow:
$9.86M
1W Performance:
-4.39%
1M Performance:
-17.10%
6M Performance:
-28.05%
1Y Performance:
-2.28%
1-Day Range:
$26.73
$28.70
1-Week Range:
$26.59
$30.42
52-Week Range:
$25.17
$42.44
Surmodics Inc Stock (SRDX) Company Profile
Name
Surmodics Inc
Sector
Industry
Phone
(952) 500-7000
Address
9924 W 74TH ST, EDEN PRAIRIE, MN
Compare SRDX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SRDX
Surmodics Inc
|
28.32 | 549.47M | 138.20M | 5.52M | 9.86M | 0.38 |
|
ABT
Abbott Laboratories
|
129.89 | 225.27B | 41.95B | 13.40B | 6.35B | 7.65 |
|
BSX
Boston Scientific Corp
|
95.37 | 140.74B | 16.75B | 1.85B | 2.37B | 1.25 |
|
SYK
Stryker Corp
|
363.66 | 138.77B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
92.33 | 118.39B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
67.95 | 39.95B | 5.72B | 4.17B | 259.90M | 6.97 |
Surmodics Inc Stock (SRDX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-07-25 | Upgrade | Lake Street | Hold → Buy |
| Jun-13-23 | Upgrade | Needham | Hold → Buy |
| Feb-13-23 | Downgrade | Needham | Buy → Hold |
| Jul-23-20 | Upgrade | Needham | Hold → Buy |
| Dec-11-19 | Downgrade | Needham | Buy → Hold |
| Nov-01-19 | Downgrade | Lake Street | Buy → Hold |
| Aug-01-19 | Reiterated | Needham | Buy |
| May-02-19 | Reiterated | Lake Street | Buy |
| May-02-19 | Reiterated | Needham | Buy |
| Feb-21-19 | Reiterated | Needham | Buy |
| May-16-18 | Reiterated | Needham | Buy |
| Mar-01-18 | Upgrade | Sidoti | Neutral → Buy |
| Feb-28-18 | Reiterated | Lake Street | Buy |
| Feb-28-18 | Initiated | Needham | Buy |
| Jul-14-17 | Initiated | Lake Street | Buy |
| Nov-21-16 | Downgrade | Barrington Research | Outperform → Mkt Perform |
| Oct-06-16 | Downgrade | Sidoti | Buy → Neutral |
| May-03-16 | Reiterated | Barrington Research | Outperform |
| Aug-06-15 | Reiterated | Barrington Research | Outperform |
| Mar-27-15 | Initiated | Dougherty & Company | Buy |
| Feb-25-14 | Initiated | Laidlaw | Buy |
| Aug-01-13 | Upgrade | Feltl & Co. | Buy → Strong Buy |
| Nov-12-12 | Reiterated | Barrington Research | Outperform |
View All
Surmodics Inc Stock (SRDX) Latest News
GTCR / Surmodics: Four Key Takeaways for M&A Antitrust from the First FTC Merger Challenge Under Trump - JD Supra
FTC sues to block GTCR’s ‘unlawful acquisition’ of Surmodics - Yahoo Finance
Medical Coating Market Projected To Witness Substantial Growth, 2025-2032: Freudenberg Medical Europe GmbH, - EIN News
Surmodics (NASDAQ:SRDX) Stock Rating Upgraded by Lake Street Capital - Defense World
Lake Street Upgrades Surmodics (SRDX) - Nasdaq
SRDX Stock Falls Following Plan for Legal Action Against FTC Challenge - MSN
Where are the Opportunities in (SRDX) - Stock Traders Daily
Deal Dispatch: Clock Ticks On TikTok, Raizen Explores Asset Sale, Investors Urge Walgreens To Go Private - Benzinga
FTC Sues to Block Sale of Surmodics - PlasticsToday
FTC targets GTCR in agency's first merger challenge under new Trump term - Crain's Chicago Business
FTC challenges private equity firm’s acquisition of Surmodics - Mass Device
FTC challenges $627M private equity takeover of Surmodics - MedTech Dive
Surmodics remains committed to GTCR merger despite US FTC suit - MLex
Why Surmodics Stock Is Falling On Friday - Benzinga
Surmodics says it will defend proposed acquisition by GTCR against FTC lawsuit - PE Hub
Lake Street Upgrades SurModics to Buy From Hold, Price Target is $43 -March 07, 2025 at 08:46 am EST - Marketscreener.com
Surmodics Vows to Oppose FTC Decision to Block GTCR Deal -March 07, 2025 at 04:39 am EST - Marketscreener.com
Rhumbline Advisers Boosts Stake in Surmodics, Inc. (NASDAQ:SRDX) - Defense World
Surmodics contests FTC challenge to GTCR acquisition By Investing.com - Investing.com South Africa
Surmodics Responds To FTC Challenge, Commits To Completing Merger With GTCR - Nasdaq
US FTC sues to block private equity purchase of medical company - Reuters
Surmodics Says Disagrees With FTC's Decision And Remains Committed To Completing Merger with GTCR - Marketscreener.com
Surmodics contests FTC challenge to GTCR acquisition - Investing.com
Will FTC Block Surmodics' $627M Deal? Company Ready for Court Battle - StockTitan
Surmodics Issues Statement on U.S. Federal Trade Commission Challenge to Proposed Acquisition of Surmodics by Funds Affiliated with GTCR - Business Wire
FTC Challenges PE Firm's Medical Device Coatings Deal - Law360
US FTC sues to block GTCR-Surmodics deal - MLex
FTC sues to block GTCR’s $627M Surmodics acquisition - Modern Healthcare
US FTC sues to block private equity buy of medical company -March 06, 2025 at 04:47 pm EST - Marketscreener.com
FTC Sues GTCR, Surmodics Over Medical Device Coatings Deal (1) - Bloomberg Law
FTC sues to block private equity firm's deal to buy medical device coatings maker Surmodics - Marketscreener.com
GTCR-Surmodics merger challenged by US FTC - MLex
FTC sues to block acquisition of Surmodics - TipRanks
Surmodics drops after FTC files suit to block its planned sale to GTCR (SRDX:NASDAQ) - Seeking Alpha
Surmodics drops on report it will meet with regulators to try to save deal - MSN
Surmodics drops on report it will meet with regulators to try to save deal (SRDX:NASDAQ) - Seeking Alpha
SurModics: Fiscal Q3 Earnings Snapshot -July 31, 2024 at 07:17 am EDT - Marketscreener.com
Phocas Financial Corp. Cuts Stock Position in Surmodics, Inc. (NASDAQ:SRDX) - MarketBeat
Surmodics Reports Successful Clinical Use of its Pounce XL Thrombectomy System - MPO-mag
Surmodics, Inc. (NASDAQ:SRDX) Shares Sold by Olympiad Research LP - MarketBeat
How to Take Advantage of moves in (SRDX) - Stock Traders Daily
Zacks Research Has Bullish Outlook for Surmodics Q2 Earnings - Armenian Reporter
What is Zacks Research’s Estimate for Surmodics Q2 Earnings? - Defense World
Q3 Earnings Forecast for Surmodics Issued By Zacks Research - Defense World
Surmodics Investigated by Block & Leviton For Potential Securities Law Violations; Investors Who Have Lost Money Are Encouraged to Contact the Firm - ACCESS Newswire
(SRDX) Technical Data - Stock Traders Daily
Surmodics shareholders approve key proposals at annual meeting - MSN
Surmodics shareholders approve key proposals at annual meeting By Investing.com - Investing.com Nigeria
Surmodics (NASDAQ:SRDX) Issues Quarterly Earnings Results - Armenian Reporter
Surmodics Q2 EPS Estimate Decreased by Barrington Research - MarketBeat
Top 3 Health Care Stocks You'll Regret Missing This Month - Benzinga
Surmodics Inc Stock (SRDX) Financials Data
Revenue
Net Income
Cash Flow
EPS
Surmodics Inc Stock (SRDX) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| DANTZKER DAVID | Director |
Feb 13 '25 |
Option Exercise |
27.30 |
5,275 |
144,008 |
44,399 |
| BEDOYA JOSE H | Director |
Feb 14 '25 |
Option Exercise |
27.30 |
5,275 |
144,008 |
34,232 |
| KNIGHT SUSAN E | Director |
Jan 24 '25 |
Option Exercise |
27.30 |
7,358 |
200,873 |
42,506 |
| Arens Timothy J. | Chief Financial Officer |
Nov 26 '24 |
Sale |
39.44 |
7,009 |
276,453 |
70,350 |
3.40%
0.89%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):